β-Cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release

被引:235
作者
Franklin, I
Gromada, J
Gjinovci, A
Theander, S
Wollheim, CB [1 ]
机构
[1] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland
[2] Lilly Res Labs, Hamburg, Germany
关键词
D O I
10.2337/diabetes.54.6.1808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon, secreted from islet alpha-cells, mobilizes liver glucose. During hyperglycemia, glucagon secretion is inhibited by paracrine factors from other islet cells, but in type 1 and type 2 diabetic patients, this suppression is lost. We investigated the effects of beta-cell secretory products zinc and insulin on isolated rat a-cells, intact islets, and perfused pancreata. Islet glucagon secretion was markedly zinc sensitive (IC50 = 2.7 mu mol/l) more than insulin release (IC50 = 10.7 mu mol/l). Glucose, the mitochondrial substrate pyruvate, and the ATP-sensitive K+ channel (K-ATP channel) inhibitor tolbutamide stimulated isolated alpha-cell electrical activity and glucagon secretion. Zinc opened K-ATP channels and inhibited both electrical activity and pyruvate (but not arginine) stimulated glucagon secretion in alpha-cells. Insulin transiently increased K-ATP channel activity, inhibited electrical activity and glucagon secretion in alpha-cells, and inhibited pancreatic glucagon output. Insulin receptor and K-ATP channel subunit transcripts were more abundant in alpha- than beta-cells. Transcript for the glucagon-like peptide 1 (GLP-1) receptor was not detected in alpha-cells nor did GLP-1 stimulate a-cell glucagon release. beta-Cell secretory products zinc and insulin therefore inhibit glucagon secretion most probably by direct activation of K-ATP channels, thereby masking an alpha-cell metabolism secretion coupling pathway similar to beta-cells.
引用
收藏
页码:1808 / 1815
页数:8
相关论文
共 50 条
  • [1] ARKHAMMAR P, 1987, J BIOL CHEM, V262, P5448
  • [2] Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response
    Banarer, S
    McGregor, VP
    Cryer, PE
    [J]. DIABETES, 2002, 51 (04) : 958 - 965
  • [3] Zinc-induced changes in ionic currents of clonal rat pancreatic β-cells:: activation of ATP-sensitive K+ channels
    Bloc, A
    Cens, T
    Cruz, H
    Dunant, Y
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2000, 529 (03): : 723 - 734
  • [4] STIMULATORY EFFECTS OF TOLBUTAMIDE INFUSION ON PLASMA-GLUCAGON IN INSULIN-DEPENDENT DIABETIC SUBJECTS
    BOHANNON, NV
    LORENZI, M
    GRODSKY, GM
    KARAM, JH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (02) : 459 - 462
  • [5] Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells
    Bokvist, K
    Olsen, HL
    Hoy, M
    Gotfredsen, CF
    Holmes, WF
    Buschard, K
    Rorsman, P
    Gromada, J
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1999, 438 (04): : 428 - 436
  • [6] EFFECT OF INSULIN ON ALPHA-CELL RESPONSE TO HYPERGLYCEMIA IN LONG-STANDING ALLOXAN DIABETES
    BRAATEN, JT
    FALOONA, GR
    UNGER, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (04) : 1017 - 1021
  • [7] Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas
    Brunicardi, FC
    Kleinman, R
    Moldovan, S
    Nguyen, THL
    Watt, PC
    Walsh, J
    Gingerich, R
    [J]. PANCREAS, 2001, 23 (03) : 302 - 308
  • [8] Evidence that extrapancreatic GLUT2-Dependent glucose sensors control glucagon secretion
    Burcelin, R
    Thorens, B
    [J]. DIABETES, 2001, 50 (06) : 1282 - 1289
  • [9] Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats
    Cejvan, K
    Coy, DH
    Efendic, S
    [J]. DIABETES, 2003, 52 (05) : 1176 - 1181
  • [10] Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism
    Ding, WG
    Renstrom, E
    Rorsman, P
    Buschard, K
    Gromada, J
    [J]. DIABETES, 1997, 46 (05) : 792 - 800